412 reports of this reaction
10.3% of all LIDOCAINE HCL reports
#1 most reported adverse reaction
DRUG HYPERSENSITIVITY is the #1 most commonly reported adverse reaction for LIDOCAINE HCL, manufactured by Chattem, Inc.. There are 412 FDA adverse event reports linking LIDOCAINE HCL to DRUG HYPERSENSITIVITY. This represents approximately 10.3% of all 3,987 adverse event reports for this drug.
LIDOCAINE HCL has an overall safety score of 72 out of 100. Patients taking LIDOCAINE HCL who experience drug hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG HYPERSENSITIVITY is a frequently reported adverse event for LIDOCAINE HCL, accounting for a significant proportion of all reports.
In addition to drug hypersensitivity, the following adverse reactions have been reported for LIDOCAINE HCL:
The following drugs have also been linked to drug hypersensitivity in FDA adverse event reports:
DRUG HYPERSENSITIVITY has been reported as an adverse event in 412 FDA reports for LIDOCAINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG HYPERSENSITIVITY accounts for approximately 10.3% of all adverse event reports for LIDOCAINE HCL, making it one of the most commonly reported side effect.
If you experience drug hypersensitivity while taking LIDOCAINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.